S100B and major depressive disorder: We present a comprehensive study aimed at identifying the causal effects of circulating S100B levels on six neuropsychiatric or neurological disorders, including neurodevelopmental (ASD and SCZ), neurodegenerative (AD and PD), and mood disorders (BIP and MDD).